 |
|
|
|
 |
Krypton
83.798 g/6.022x10^23

Registered: Nov 2003
Location: Texas
|
|
|
Oct-09-2007 16:37
|
|
|
 |
 |
|
 |
 |
|
 |
 |
Krypton
83.798 g/6.022x10^23

Registered: Nov 2003
Location: Texas
|
|
|
NanoGen Inc. (NGEN) - $0.93 (October 15, 2007)
Nanogen, Inc. (Nanogen) provides advanced diagnostic products. As of March 16, 2007, the Company was developing several product lines that directly target specific markets within the advanced diagnostics field. Its diagnostic technologies focus on the identification of the nucleic acid sequences, gene variations and gene expressions associated with both genetic conditions and infectious diseases. Nanogen has four categories of advanced diagnostic technologies: molecular testing platforms molecular reagents point-of-care tests and advanced genetic markers. On February 6, 2006, Nanogen acquired the rapid cardiac immunoassay point-of-care test business of Spectral Diagnostics Inc. The acquired products include rapid tests for levels of CKMB, Myoglobin and Troponin, all of which are frequently used in cardiac care. On May 1, 2006, it completed the acquisition of the diagnostics division of Amplimedical S.P.A.
------------------------------------------------
NGEN is currently operating with 2 times more expenses than income. That means the company is not profitable, and has not been for at least 5 years... http://moneycentral.msn.com/investo...A=1&Type=Equity
The fundamental strength (FS) is 42. The relative strength is 8. This means the stock has done way worse than it actually is worth. In my strategy, as I said, I like see FS of at least 80 for me to consider buying.
Well, here is my valuation...

My average valuation for NGEN is that its worth $1.48. Now lets go back to the fundamental strength and relative strength. Based on the FS, I think the stock is worth $1.26. These valuations project that you should have huge returns for the year. But when I look at the fundamentals of the business, NGEN is not making profits, and is operating at a loss. Just know that the projections are positive, but this is a risky play.
___________________
|
|
Oct-15-2007 23:13
|
|
|
 |
 |
venomX
ISO salty whenches

Registered: Apr 2001
Location: Vancouver, Canada
|
|
|
Well I think a good question to ask is, are they operating at a loss because they are investing in capital assets or maybe in R&D? Or this just regular operating cost (i.e. salaries, accumulated depreciation of assets,etc...)?
If the investment is in capital assets, such as land for new factories, or if it is in R&D in order to decrease costs and increase the value of their products, I would think it might be a less risky bet than if the the loss is due to operating costs.
edit: In other news, I've included some other stock in my fund. I've bought some America Movil (AMX) stock. It's gone down today, not sure why. I think it is a good bet in the long term. They are increasing their presence in Latin America, usually in countries that are reasonably stable. I have also seen them operate. They adapt quickly to the demands of the particular country they are operating in. I have yet to master the whole analysis part of this, but looking at their quarterly earnings, they have increase net income YoY as well as revenue by quite a bit. What do you guys think of this pick?
___________________
Poetry>Byron//Blog>TheMean
| quote: | Orbax
At that point you kind of crossed the rubicon and you might as well lay siege to Rome |
|
|
Oct-16-2007 00:47
|
|
|
 |
 |
Krypton
83.798 g/6.022x10^23

Registered: Nov 2003
Location: Texas
|
|
|
| quote: | Originally posted by venomX
Well I think a good question to ask is, are they operating at a loss because they are investing in capital assets or maybe in R&D? Or this just regular operating cost (i.e. salaries, accumulated depreciation of assets,etc...)?
If the investment is in capital assets, such as land for new factories, or if it is in R&D in order to decrease costs and increase the value of their products, I would think it might be a less risky bet than if the the loss is due to operating costs. |
Well, let me take a closer look... This will be for 2006...
NGEN took in $26.85 million. Now, it cost $13.29 million to make their products. After the cost of goods, NGEN has $13.56 million left (Gross Profit).
Salaries, bills, and admin cost $33.39 million. That alone bring NGEN into the negative territory on their balance sheet. Not only do they have no profit left, they now have to spend more than they make. I consider this HIGHLY risky. On R&D, they spent $25.68 million, also way more than than they have left after bills and other expenses.
When you subtract all their expenses from their revenue, they are lost $49 million in 2006. Not only that, but they've been losing tens of millions of dollars a year for at least the past 5 years. My question is where are they getting all this money? This would probably explain why they've kept issueing more and more shares. From 24.4 million shares in 2003 to 67.1 million in 2006. That's more than double! Even more risky! I also looked at their 2007 income statement, and its no different. They are still losing millions of dollars.
Yes they've increased revenue more than 5 times in two years, but their expenses still far outweigh their income. I wouldn't even touch this company with $1. You will never find me investing in unprofitable companies no matter how good they sound. If their accounting statements show negatives, why put money into paying their debts? You want profits, not debts right?
___________________
|
|
Oct-16-2007 01:37
|
|
|
 |
 |
|  |
All times are GMT. The time now is 13:05.
Forum Rules:
You may not post new threads
You may not post replies
You may not edit your posts
|
HTML code is ON
vB code is ON
[IMG] code is ON
|
|
|
|
|
|
Contact Us - return to tranceaddict
Powered by: Trance Music & vBulletin Forums
Copyright ©2000-2026, Jelsoft Enterprises Ltd.
Privacy Statement / DMCA
|